Cód QR

Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis

Standard of care radiotherapy and chemotherapy have shown limited efficacy in pancreatic ductal adenocarcinoma (PDAC). Immunotherapy has emerged as a promising treatment but has been hindered by systemic toxicities. A shift from systemic to localized delivery has reduced adverse effects and improved...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Tara G. Vrooman, Emily R. Quarato, Gary Hannon, Noah A. Salama, Maggie L. Lesch, Angela L. Hughson, Vedika S. Chandak, Nataliia Vdovichenko, Zhiming Jin, Ronald Lakony, Jian Ye, Sarah L. Eckl, Sidney Lesser, Edith M. Lord, David C. Linehan, Haoming Qiu, Nadia Luheshi, Jim Eyles, Laura M. Calvi, Scott A. Gerber
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Taylor & Francis Group 2026-12-01
Sraith:OncoImmunology
Ábhair:
Pancreatic ductal adenocarcinoma
hematopoietic stem cells
stereotactic body radiation therapy
interleukin-12, bone marrow
hematopoiesis
Rochtain ar líne:https://www.tandfonline.com/doi/10.1080/2162402X.2026.2682058
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla